PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Cellectar Biosciences, Inc.
Filed: April 10, 2015
Period of Report: April 10, 2015
Accession Number: 0001144204-15-022279

View Document ↗ View on SEC.gov ↗